Literature DB >> 6210653

Comparative in-vitro activity of MK0787 (N-formimidoyl thienamycin) against 540 blood culture isolates.

D L Cohn, L G Reimer, L B Reller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6210653     DOI： 10.1093/jac/9.3.183

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  10 in total

1.  In vitro susceptibilities of clinical isolates of cysteine-requiring Escherichia coli to 12 antimicrobial agents.

Authors:  C J McIver; J W Tapsall
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

2.  Imipenem susceptibility testing with a commercially prepared dry-format microdilution tray.

Authors:  J L Staneck
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

3.  Bile levels of imipenem in patients with T-drain following the administration of imipenem/cilastatin.

Authors:  M Mayer; C Tophof; W Opferkuch
Journal:  Infection       Date:  1988 Jul-Aug       Impact factor: 3.553

4.  Stability of imipenem in Mueller-Hinton agar stored at 4 degrees C.

Authors:  P L Turgeon; C Desrochers
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

5.  Comparative evaluation of penicillin, ampicillin, and imipenem MICs and susceptibility breakpoints for vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.

Authors:  M P Weinstein
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

6.  [Effect and tolerance of daily 2 X 1 g imipenem/cilastatin in general surgery].

Authors:  M Wenzel; H Loch
Journal:  Infection       Date:  1986       Impact factor: 3.553

Review 7.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

8.  Bioactivity of imipenem as a function of medium, time, and temperature.

Authors:  E J Baron; J A Hindler
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

9.  Pseudoresistance of Pseudomonas aeruginosa resulting from degradation of imipenem in an automated susceptibility testing system with predried panels.

Authors:  R L White; M B Kays; L V Friedrich; E W Brown; J R Koonce
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

10.  Multicenter evaluation of use of penicillin and ampicillin as surrogates for in vitro testing of susceptibility of enterococci to imipenem.

Authors:  Melvin P Weinstein; Stanley Mirrett; Saman Kannangara; Jan Monahan; Lizzie J Harrell; Alan C Wilson; L Barth Reller
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.